ArticlePLOS mental health2025
Healthcare use in individuals with and without attention-deficit/hyperactivity disorder: A population-based longitudinal matched cohort study.
Article in PLOS mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Individuals with Attention-Deficit/Hyperactivity Disorder (ADHD) experienced worsening symptoms during the COVID-19 pandemic resulting in increased demand for healthcare services. However, it is unclear how those with and without ADHD utilized these services during the COVID-19 pandemic. This study examined healthcare utilization among individuals with and without ADHD and as a secondary objective, investigated these trends among female and male subgroups, from April 1, 2014-March 31, 2023. We conducted a population-based longitudinal retrospective cohort study among ADHD cases identified using a validated algorithm, and controls from Ontario, Canada over the same study period. We matched ADHD cases 1:1 to controls by sex, birth year, and geographical area. Outcomes were number of outpatient visits per person per fiscal year to family physicians, for mental health and to emergency departments, stratified by sex and age group over the follow-up period. Crude visit rate differences between sex-specific cases and controls were calculated with 95% confidence intervals (CI). We matched 427 716 ADHD cases to 427 716 controls. ADHD cases were 163 528 ≤ 17 years (32% female), and 264 188 adults (52% female). From 2013-2024, where March 17, 2020 marked the onset of the COVID-19 pandemic, females aged 1-17 years with ADHD appeared to have higher visit rate differences to family physicians, emergency departments, and increased mental health services, relative to their controls, particularly in 2020 [2.66 (95% CI: 2.65-2.68)]. In the same year, males with ADHD still had a higher mental health visit rate difference, [2.02 (95% CI: 2.01-2.02)] in 2020, but lower than that observed in females. Adult females with ADHD had the highest mental health visit rate difference in 2020 [5.09 (95% CI: 5.07-5.11)] and males with ADHD had 4.41 (95% CI: 4.40-4.43). These higher service utilization differences likely reflected greater health needs among females with ADHD while males underutilized these services.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.